In my last post, I began with a question from Christy. Her facility was considering banning gabapentin from their facility due to rampant abuse and diversion problems. My last post dealt with gabapentin’s interesting history and the evidence base for off-label gabapentin prescribing. This JailMedicine post will deal with the pros and cons of banning gabapentin versus creating rules to regulate gabapentin use and hopefully minimize diversion and abuse.
The main points from the last post were:
- Gabapentin is FDA approved for seizures and post herpetic neuralgia.
- However, most of the demand for gabapentin and prescriptions for gabapentin are for “off-label” uses, namely for chronic neuropathic pain. Evidence for gabapentin use for other types of chronic pain is not so good.
- Despite the poor evidence base, gabapentin is very widely prescribed for all types of chronic pain. It is also used as a sleeping aid, restless leg syndrome, anxiety and all sorts of other stuff.
- Gabapentin has a euphoric and dissociative effect and so is very sought after as a drug of abuse in jails and prisons.
- Gabapentin is not DEA regulated and most non-correctional physicians have no clue that it can be—and is—abused.
We correctional physicians need to put this all together in order to make a rational and effective policy regarding gabapentin use in our facilities. Basically, we must balance the potential benefits of gabapentin against the potential harm to the patient and the potential harm to the institution when it is diverted and misused.
Our basic options are:
- Ban gabapentin outright.
- Restrict its use by defining exactly what use is acceptable and what we will not allow.
- Allow unrestricted use as a formulary medication—although I doubt that any correctional facility that has had experienced a gabapentin “feeding frenzy” is going to opt for this last one!
Which of these options you pick depends (in my mind at least) on whether you are a jail or a prison. Let’s look at these two situations in detail.
Gabapentin rules for jails.
One basic goal of jail medicine that makes it different from prison medicine is this: Continuity of Outside Care. The average jail patient had a medical provider before coming to jail and will return to that same medical provider when he leaves jail—in an average of, say, two weeks. Assuming that our patient had competent medical care before coming to jail, to a large degree, our job is to continue that care, hopefully without significant interruption. If the patient takes medications for hypertension, seizures, hyperthyroidism or a host of other problems, I usually will want to continue those medications for the short time that the patient is in jail, even if I myself would not treat the patient in exactly the same way.
If gabapentin has been prescribed for seizures (even though it is a crappy seizure drug), I will not want to discontinue the gabapentin while in jail. However, most of the gabapentin prescriptions that I am going to see in newly booked jail patients are going to be for (yes, you guessed it) chronic pain. If I ban gabapentin for this, I have the following considerations:
- Gabapentin should not be abruptly stopped. It needs to be tapered at a rate of no more than 300mg a day. If a patient comes in taking 3600mg a day, it will take a minimum of two weeks to safely taper her off of the gabapentin.
- When she is released from jail (in an average of two weeks.), the gabapentin will just be immediately restarted.
My thinking is that I have not accomplished much in this scenario. I didn’t accomplish my goal of not allowing gabapentin in the facility—it was there during the taper. I didn’t win friends. The jail patient will be angry and so probably will his outside physician. I did not improve his overall medical care. So if the patient is only going to be in jail for a short time, and if he supplied the gabapentin in appropriately labeled prescription bottles, I will likely continue the gabapentin for his short jail stay.
However, there are limits to this. First, the gabapentin prescribing by the outside physician must conform to commonly acceptable standards. I once had a patient who arrived at the jail taking a monster dose of 5,400 mg of gabapentin a day. I verified that this jaw-dropping prescription was correct by calling the prescribing doctor’s office. 5,400 mg of gabapentin a day far, far exceeds the maximum dose for gabapentin for any indication, which is 3600mg a day. More investigation led me to believe that this patient had been selling his gabapentin on the street, which is why he had pushed the outside prescriber for more and more gabapentin. Interesting incidental point: gabapentin has street value outside of jails and prisons!
Also, gabapentin prescribed for neuropathic pain has an evidence base in the literature. Gabapentin as a sleeping aid does not. I will view the situation differently if someone arrives at the jail taking, say, 100mg of gabapentin every night as a sleeper.
Finally, I myself do not prescribe gabapentin (well, rarely, anyway). If a patient cannot supply their own prescribed gabapentin, I’m not going to fill in the gap. Once a patient’s outside medication supply runs out, I’m not going to refill it for them. I usually will call their outside practitioner and discuss my plan to taper and discontinue the gabapentin in this patient, who is going to be incarcerated for a while. Almost always, the outside practitioner will have no problem with this. But I should make the call anyway in order to accomplish two goals: first, the outside provider and I are united in this treatment decision. Now, the inmate cannot exploit a perceived difference of opinion: “My outside doctor wants me to be on gabapentin. Who are you to deny it?” Second, I have educated the outside practitioner about the abuse potential of gabapentin. Most of them have no idea.
Gabapentin prescribing in prisons
The situation in prison is different than a short stay in jail. The medical care of the prison patient is being transferred to the prison medical providers lock, stock and barrel. These patients will not be returning to their outside medical provider anytime soon. It is akin to a person moving to another city and finding a new primary care physician to take over their medical care. The physician in the new city is under no obligation to continue therapies (like gabapentin) that she considers to be inappropriate or less than optimal. Same thing in a prison: the prison practitioner can certainly modify a treatment plan to fit the patient’s new prison environment.
Because they feel no pressure to continue outside treatment plans, some prison systems have decided to ban gabapentin entirely. The main driving force for this, of course, is the level of diversion and abuse in that particular prison system. Gabapentin abuse is a bigger problem for some prisons than for others.
But a total ban on gabapentin is not as easy as it seems. Some prison systems have banned gabapentin only to return to allowing controlled use of gabapentin later due to the problems of implementing a total ban. Whether you ban gabapentin entirely or just try to beat it into submission with guidelines of appropriate use, here are the issues you are going to have to address:
What are you going to substitute for gabapentin?
Now, if the gabapentin was prescribed for seizures, it is easy to come up with a list of alternative seizure medications. Ditto restless leg syndrome–there are better and cheaper alternatives. There are also lots of substitutes for gabapentin prescribed for psychiatric conditions like Bipolar disorder.
But all of those will likely represent only a small minority of incoming gabapentin prescriptions. Most of the gabapentin prescriptions will be for The Big Two: diabetic neuropathy and chronic pain. There certainly are other medications that can be used to treat diabetic neuropathy and chronic pain—just not very many. Here is the list:
- Duloxetine (Cymbalta). Duloxetine is, in my mind at least, the single best alternative. Its efficacy is just as good as gabapentin in randomized trials. I have not heard any reports of significant abuse or diversion of duloxetine. Perfect!
- Venlafaxine. Like duloxetine, venlafaxine has consistently outperformed gabapentin as a treatment of neuropathic pain in blinded trials. However, venlafaxine can itself has been diverted and abused in correctional settings.
- Tri-cyclic antidepressants, especially amitriptyline. TCAs have also been successfully used to treat chronic pain. The problem with TCAs is twofold: first, they themselves, especially amitriptyline, can be diverted and abused. Also, TCAs can be deadly in overdose. I myself have personally witnessed two deaths caused by TCA overdose (in my ER days). TCAs also have lots of interactions with other medications. If you do use TCAs, use a low dose. Big doses do not improve efficacy, but do increase the possibility of overdose. Also, I would recommend using a TCA with less diversion potential like nortriptyline.
- Other antidepressants. I have seen SSRIs prescribed for chronic pain. I have also not heard of significant abuse or diversion of SSRIs. The problem with them is that they have not been well studied as treatments for neuropathic pain.
- Other seizure medications like Keppra, Tegretol and Depakote. These also have been used for chronic pain but, like SSRIs, do not have a great literature base.
- Capsaicin cream. Interestingly, capsaicin cream performed just as well as did gabapentin in the trials! A definite possibility.
- Pregabulin (Lyrica). The problem with Lyrica in corrections is that it is just as abusable/divertable as is gabapentin. In fact, they both act on the same receptors. In my mind, it basically is the same thing as gabapentin–only worse. Where gabapentin is not a DEA controlled substance, Lyrica is. Lyrica is also expensive. You have accomplished little if you replace gabapentin with Lyrica.
“Nothing Works Except Gabapentin”
The next thing you need to decide is what you are going to do when these substitutions fail. Many patients who are switched to the new agents will do fine. But there will be some who are going to say that nothing else works except gabapentin. Some of these are sincere–gabapentin can be a great drug for some patients. But others who say that only gabapentin works want it to abuse or divert. It often is impossible to tell the difference between these two categories.
If gabapentin is totally banned, some inmates will inevitably file grievances, tort actions and complaints to the state medical board that they are being denied “the only medical therapy that works for me.” They will enlist family members and outside doctors and advocacy groups to lobby for them. I know of a couple of prison systems where complaints like these became such a problem that they reversed their decision to ban gabapentin outright. Be prepared!
If your facility is going to ban gabapentin nevertheless, I would strongly recommend that this be an official decision with the agreement of everyone involved: the Medical Director, the Director of Nursing, a representative of your pharmacy, the security administrator of your facility and your legal representative. Having agreement from this diverse group beforehand will go a long way to deal with the inevitable backlash.
The argument against banning gabapentin in prisons.
One of my mentors in prison medicine argues against a total ban on gabapentin in prisons. His reasoning goes like this:
1. 95% of the inmates prescribed gabapentin do not divert or abuse. Gabapentin can be a useful and effective drug for them. Why ban use in the 95% because of the 5% who abuse it?
2. Also, he says, the 5% who are abusing gabapentin are going to divert and abuse some type of medication no matter what. Since gabapentin is relatively safer in an overdose than, say, tricyclic antidepressants or bupropion, it is better that the inevitable prison black market be for the safer drug–gabapentin.
3. Instead, says my mentor, it is possible to make and enforce rules for rational and sane gabapentin prescribing.
Rules for gabapentin prescribing.
Here are some rules for gabapentin prescribing for neuropathy and chronic pain that I think are reasonable and in line with the literature.
Decide who you will be eligible for a gabapentin prescription. As I discussed last week, gabapentin has been basis in the literature as a treatment for neuropathic pain. It is not a viable treatment for “nociceptive” musculoskeletal pain. So diabetics who complain of painful feet might be proper candidates for a gabapentin prescription, whereas a patient with, say, chronic knee pain due to DJD is not a proper candidate according to the literature.
Decide what medications for neuropathic pain should be tried before gabapentin. Since several other medications work just as well–or better–for neuropathic pain than does gabapentin and do not have the abuse potential that gabapentin does, I would recommend that gabapentin be a drug of last resort. Better agents include duloxetine, venlafaxine, tricyclics and capsaicin cream.
Set the maximum dosages. If you look up maximum gabapentin dosage for neuropathy in one of the many drug compendiums (Tarascon, say), it will give the maximum dosage as 3,600 mg a day. And it is true that doses this high have been used in gabapentin studies. But what Tarascon does not tell you is that the studies showed that high doses of gabapentin were no more effective than low doses–but high doses do increase the incidence of gabapentin side effects and, in our world, availability for diversion, abuse and overdose.
So what should the maximum dosage of gabapentin be for neuropathic pain? Well, interestingly, Pfizer, the original maker of Neurontin, answered this question for us. Remember that Neurontin was FDA approved for one type of neuropathy– post herpetic neuropathic pain. And the Neurontin package insert lists the maximum dose for this neuropathic pain as 1,800 mg a day. So there is your answer. Maximum dose of gabapentin for neuropathy is 1,800 mg a day.
Once again, though, almost all of the benefit from gabapentin is gained at doses much lower than this theoretical maximum dose. The Prescriber’s Letter (which is my favorite pharmacy information source) says this (Here): “gabapentin doses above 900 mg/day don’t provide much more pain relief–but do increase side effects. Keep in mind there’s a diminishing return with higher doses . . . doubling the dose does not double drug concentration.”
So although the theoretical maximal dose is 1,800mg a day, the effective maximum dose is just 900mg a day.
Monitor compliance. It is easy to check compliance with prescribed gabapentin. You just need to draw a gabapentin drug level. Decide how often these will be. Will they be scheduled or random? Will you check levels in all patients or just those who you suspect of diversion?
Decide what you will do with those caught diverting. Since gabapentin is not a “must-have” medication, I would recommend that anyone caught diverting gabapentin have their gabapentin prescription stopped. You will need to decide how long until the inmate will be eligible for another trial. Six months? One year? Whatever it is, it must be consistent.
Uniform prescribing. Whatever rules or guidelines you develop for gabapentin use, it is essential that they be followed by all the prescribers in your system and, if you have multiple facilities in your system, at all facilities. Having even one practitioner who ignores your guidelines will result in grievances, complaints and gaming.
As always, the views I have expressed here are my own opinions and the result of my own training and experience. I could be wrong! You should carefully review the evidence for gabapentin prescribing yourself!
How do you handle gabapentin in your facility? I’d like to hear from those of you who work at facilities where gabapentin is banned. Was the ban successful? I’d also like to hear from those who have tried to regulate gabapentin. What are your rules? What works? What does not work? Please Comment!